In prostate cancer cell lines, β-Catenin enhances androgen-stimulated AR transcriptional activation and increases sensitivity to low levels of androgens and to non-androgen ligands [17], [18], [19], [20], [21], [22]. This evidence concerns the gene AR and prostate carcinoma.